1. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. (June 2021) Authors: Avouac, Jérôme; Drumez, Elodie; Hachulla, Eric; Seror, Raphaèle; Georgin-Lavialle, Sophie; El Mahou, Soumaya; Pertuiset, Edouard; Pham, Thao; Marotte, Hubert; Servettaz, Amélie; Domont, Fanny; Chazerain, Pascal; Devaux, Mathilde; Claudepierre, Pascal; Langlois, Vincent; Mekinian, Arsène; Maria, A... Journal: Lancet Issue: Volume 3:Number 6(2021) Page Start: e419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. (December 2021) Authors: Sattui, Sebastian E; Conway, Richard; Putman, Michael S; Seet, Andrea M; Gianfrancesco, Milena A; Beins, Kaley; Hill, Catherine; Liew, David; Mackie, Sarah L; Mehta, Puja; Neill, Lorna; Gomez, Gimena; Salinas, Maria Isabel Haye; Maldonado, Federico Nicolas; Mariz, Henrique Ataide; de Sousa Studar... Journal: Lancet Issue: Volume 3:Number 12(2021) Page Start: e855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗